MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Anti-GAD antibody cerebellar ataxia mimicking multiple system atrophy

    J.B. Parmera, L.S.V. Schneider, R.G. Cury, M.M. Simabukuro, L.H.M. Castro, E.R. Barbosa (São Paulo, Brazil)

    Objective: To describe a case of anti-glutamic acid decarboxylase antibody (GAD-Abs)-associated cerebellar ataxia (CA), which presented with gradual dysautonomia and parkinsonism fulfilling criteria for MSA,…
  • 2016 International Congress

    Clinical and analytical validation of novel autosomal recessive ataxia mutations identified from whole exome sequencing

    S. Shakya, R. Kumari, A.K. Srivastava, D. Dash, A. Takkar, I. Singh, A. Garg, M. Mukerji, M. Faruq (New Delhi, India)

    Objective: To establish clinical significance of novel recessive ataxia mutations by phenotype-genotype correlation and screening of mutations in second cohort of recessive ataxia patients and…
  • 2016 International Congress

    Evidence of striatal dopaminergic dysfunction Sydenham’s chorea in remission with (99m)Tc-TRODAT-1 SPECT

    R. Maciel, D. Maia, C.F. de Lima, F. Cardoso (Belo Horizonte, Brazil)

    Objective: To report the findings of reduced striatal dopamine transporter (DAT) density in patients with Sydenham's chorea (SC) in remission assessed by single-photon emission computed…
  • 2016 International Congress

    Tractography study of individuals with mutation for Huntington’s disease in symptomatic and pre-symptomatic phases

    R.A. Saba, J. Yared, T. Doring, V. Borges, L.B. Barcelos, H.B. Ferraz (São Paulo, Brazil)

    Objective: Identify the involvement of white matter tracts in HD, using this technique and, thus, evaluate it as a potential biomarker for the disease. Background:…
  • 2016 International Congress

    Emotional facial EMG responses are affected in Huntington’s disease

    C.C. Kordsachia, I. Labuschagne, J. Stout (St. Kilda, Australia)

    Objective: The aim of this study was to investigate emotional facial muscle responses in Huntington's Disease (HD). We examined induced experience-related responses when viewing emotional…
  • 2016 International Congress

    Interleaved pro- and anti-saccade performance in Huntington’s disease

    I. Vaca-Palomares, J. Fernandez-Ruiz, B. Coe, D.P. Munoz (Kingston, ON, Canada)

    Objective: To investigate suppression of automatic movements and execution of voluntary motor commands in an early stage Huntington's disease patients. Background: The ability to suppress…
  • 2016 International Congress

    MRI diagnostics child cerebral palsy with symptomatic epilepsy

    D. Aminova (Tashkent, Uzbekistan)

    Objective: The aim of the study was to determine characteristics of MRI studies in symptomatic epilepsy with child cerebral palsy. Background: Cerebral palsy (CP) is…
  • 2016 International Congress

    Iron accumulation in a Wilson disease patient: Longitudinal 7T MRI and transcranial sonography study

    P. Dusek, D. Skoloudik, J. Maskova, T. Huelnhagen, R. Bruha, D. Zahorakova, T. Niendorf, E. Ruzicka, S.A. Schneider, J. Wuerfel (Prague, Czech Republic)

    Objective: To investigate longitudinal changes in clinical symptoms, 7T MRI and transcranial sonography (TCS) during chelating treatment in a Wilson disease (WD) patient. Background: Pathophysiological…
  • 2016 International Congress

    Mirror movements in Moebius syndrome: Mirroring beyond movements

    H.J.S. Cho, P. Panyakaew, M. Hallett (Bethesda, MD, USA)

    Objective: To understand pathophysiology of mirror movements (MM) in Moebius syndrome patients by performing comprehensive neurophysiologic studies in two patients. Background: MM are involuntary movements…
  • 2016 International Congress

    The role of cathepsin L involved in the activation of microglia and Parkinson’s disease

    S. Xu, X. Yang, H. Zhang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate the role of lysosomal protease cathepsin L in the activation of microglia and the injury of dopaminergic neurons, and further to interpret…
  • « Previous Page
  • 1
  • …
  • 169
  • 170
  • 171
  • 172
  • 173
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley